- Home
- ZEPP vs DTIL Comparison
ZEPP vs DTIL Comparison
Compare ZEPP & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZEPP
- DTIL
- Stock Information
- Founded
- ZEPP 2013
- DTIL 2006
- Country
- ZEPP China
- DTIL United States
- Employees
- ZEPP N/A
- DTIL N/A
- Industry
- ZEPP Computer Manufacturing
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- ZEPP Technology
- DTIL Health Care
- Exchange
- ZEPP Nasdaq
- DTIL Nasdaq
- Market Cap
- ZEPP 44.0M
- DTIL 44.1M
- IPO Year
- ZEPP N/A
- DTIL 2019
- Fundamental
- Price
- ZEPP $3.02
- DTIL $4.96
- Analyst Decision
- ZEPP
- DTIL Strong Buy
- Analyst Count
- ZEPP 0
- DTIL 3
- Target Price
- ZEPP N/A
- DTIL $37.67
- AVG Volume (30 Days)
- ZEPP 16.2K
- DTIL 1.3M
- Earning Date
- ZEPP 11-18-2024
- DTIL 11-04-2024
- Dividend Yield
- ZEPP N/A
- DTIL N/A
- EPS Growth
- ZEPP N/A
- DTIL N/A
- EPS
- ZEPP N/A
- DTIL 1.45
- Revenue
- ZEPP $208,946,095.00
- DTIL $75,096,000.00
- Revenue This Year
- ZEPP N/A
- DTIL $52.95
- Revenue Next Year
- ZEPP $18.94
- DTIL N/A
- P/E Ratio
- ZEPP N/A
- DTIL $2.57
- Revenue Growth
- ZEPP N/A
- DTIL 43.62
- 52 Week Low
- ZEPP $2.06
- DTIL $3.61
- 52 Week High
- ZEPP $6.44
- DTIL $19.43
- Technical
- Relative Strength Index (RSI)
- ZEPP 53.21
- DTIL 46.54
- Support Level
- ZEPP $2.81
- DTIL $5.10
- Resistance Level
- ZEPP $3.30
- DTIL $7.44
- Average True Range (ATR)
- ZEPP 0.29
- DTIL 0.66
- MACD
- ZEPP 0.02
- DTIL 0.14
- Stochastic Oscillator
- ZEPP 57.65
- DTIL 35.25
About ZEPP Zepp Health Corporation
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in two segments: Xiaomi Wearable Products and Self-branded products & others. The product portfolio includes smartwatches and fitness bands. The majority is from Self-branded products & other segments. It generates majority of the revenue from Xiaomi Wearable Products segment.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.